Infection with cytomegalovirus (CMV) continues to be one of the most common complications following allogeneic bone marrow transplantation. To study the role of CMV in the suppression of hemopoiesis that frequently accompanies infection, we investigated the effect ofCMV on the growth ofisolated committed myeloid progenitors and on hemopoiesis in long-term bone marrow cultures. Laboratory strain AD169 had no effect on the growth and development of progenitor cells. In contrast, 40% of clinical isolates of CMV inhibited colony formation by up to 100%. In long-term bone marrow cultures all CMV isolates resulted in myelosuppression, which in the majority of cases was associated with the infection of stromal elements. Analysis of RNA from stromal cells infected with AD169 and one clinical isolate demonstrated a specific deficiency of granulocyte colony-stimulating factor transcripts. For a small proportion of the clinical isolates tested in long-term bone mlarrow cultures, suppression of hemopoiesis was correlated Okh infection of developing granulocytes. These studies suggest that CMV can impair hemopoiesis either through infection of stromal cells and consequent perturbation of growth factor production or by direct infection of myeloid cells.
ofisolated committed myeloid progenitors and on hemopoiesis in long-term bone marrow cultures. Laboratory strain AD169 had no effect on the growth and development of progenitor cells. In contrast, 40% of clinical isolates of CMV inhibited colony formation by up to 100%. In long-term bone marrow cultures all CMV isolates resulted in myelosuppression, which in the majority of cases was associated with the infection of stromal elements. Analysis of RNA from stromal cells infected with AD169 and one clinical isolate demonstrated a specific deficiency of granulocyte colony-stimulating factor transcripts. For a small proportion of the clinical isolates tested in long-term bone mlarrow cultures, suppression of hemopoiesis was correlated Okh infection of developing granulocytes. These studies suggest that CMV can impair hemopoiesis either through infection of stromal cells and consequent perturbation of growth factor production or by direct infection of myeloid cells.
Human cytomegalovirus (CMV), a member of the herpesvirus family, infects the majority ofthe population by adulthood (1) . The consequences of CMV infection ranges from subclinical asymptomatic illness to a rapidly progressive disseminated disease in immunocompromised individuals. In patients undergoing bone marrow transplants, CMV can be associated with delayed platelet engraftment (2) , phenotypically abnormal peripheral blood leukocytes (3) , and graft failure (4) .
Several mechanisms acting alone or in combination could mediate the myelosuppression associated with CMV. Hemopoietic progenitor cells or accessory cells such as monocytes and T lymphocytes, hypothesized to provide growth factors, may be targets for infection (5) (6) (7) (8) . Alternatively, since the maintenance of primitive hemopoietic progenitor cells is crucially dependent on their interactions with stromal cells of the marrow microenvironment (9) , the perturbation of stromal cell function by CMV could also result in myelosuppression.
We studied the myelosuppressive effects of CMV in vitro using a laboratory-adapted strain and low-passage clinical isolates to infect human long-term bone marrow cultures (LTBMC) Highly enriched populations of progenitor cells, free of contaminating accessory cells, were incubated with AD169 or clinical isolates (Table 1 ). AD169 and 12 of 19 clinical isolates had no effect on the growth of colonies nor was viral IEA detected in cytospin preparations. However, 8 clinical isolates inhibited growth of CFU-GM, BFU-E, and CFU-Mix colonies, ranging from 17% to 100% of growth obtained in mock-infected control cultures.
Addition of CMV to LTBMCs: Effects on Hemopoiesis. CMV has been demonstrated to infect and replicate in bone marrow-derived stromal cells of simian and human origin (21, 22) . To investigate whether infection with CMV impaired the ability of marrow stromal cells to maintain hemopoietic development, LTBMCs established from normal seronegative donors were inoculated with AD169 virus, and cultures were monitored on a weekly basis by assessing nonadherent cell production and phenotype. The results of a representative experiment are shown in Fig. 1 . Cultures inoculated with AD169 showed rapid and progressive decreases in weekly nonadherent cell production, including dramatic reductions in the numbers of nonadherent day 7 CFU-GM as well as day 14 BFU-E and CFU-Mix.
The effect of adding CMV clinical isolates to LTBMCs was similarly assessed (Fig. 2) . All five CMV isolates tested resulted in variable but marked reductions in nonadherent cell production with time. Within 1 week of addition of virus, day 7 CFU-GM numbers fell by 130-fold, day 14 BFU-E fell by 80-fold, and CFU-Mix numbers were reduced to undetectable levels. Similar results have been obtained with an additional 10 clinical CMV isolates.
Identification of CMV-Infected Cell Types in LTBMCs. As summarized in Table 2 ( Fig. 3 A, B , E, and F), adipocytes and nonphagocytic fibroblast-like cells were found to express Medical Sciences: Simmons et al. granulocytes remained negative. However, unlike AD169, these CMV isolates infected between 1% and 5% of macrophages and endothelial cells (Fig. 3 C and D) . . 3 5 7 9 1 3 5 7 9 Proc. Natl. Acad. Sci. USA 87 (1990) Effect of CMV on Growth Factor Production by Adherent Cells. Serum-free medium conditioned by the growth of AD169-infected and mock-infected LTBMC cultures was assayed for the presence of activities stimulating the growth of CFU-GM and BFU-E (Table 3) . Conditioned medium from control cultures increased the growth of BFU-E relative to controls and supported moderate numbers of CFU-GM. Conditioned medium from CMV-infected cultures had moderate burst-promoting activity but lacked activities stimulating CFU-GM. Titration ofthe CMV-conditioned medium over the range of 1-20% against optimal concentrations of purified recombinant interleukin 3, GM-CSF, or G-CSF did not reveal the presence of any inhibitory activities (data not shown).
The same LTBMCs were used to evaluate the levels ofRNA transcripts for G-CSF, M-CSF, and GM-CSF. RNA was extracted from the stromal adherent layers 24 hr after feeding and analyzed by means of an RNase protection assay. As shown in Fig. 4A , mock-infected control cultures demonstrated transcripts for all three CSFs. In contrast, LTBMCs infected with AD169 showed no detectable G-CSF mRNA.
Finally, CSF transcripts in normal LTBMCs infected with two different CMV clinical isolates were also studied. The results of the RNase protection assays (Fig. 4B ) demonstrate no effect of either isolate on GM-CSF transcripts but varied effects on M-CSF transcripts. Infection with CMV I (8592) resulted in the disappearance of G-CSF transcripts as observed in LTBMCs infected with the AD169 strain of virus. Conversely, with CMV II (5009) levels ofG-CSF, mRNA was increased with respect to control.
DISCUSSION
Although many reports document the presence of CMV IEA in leukocytes (6) (7) (8) (23) (24) (25) (26) (27) , evidence of viral replication with a potential role in myelosuppression has not been demonstrated (6, 7, 25) , with one exception (27) . Our current report demonstrates growth inhibition of myeloid, erythroid, and multipotential progenitor cells by 8 of 20 clinical isolates of CMV. These results are at variance with those of Apperley et al. (22) , who failed to show inhibition of growth with 4 of 4 low-passage clinical isolates.
We were unable to find any effect of the laboratoryadapted strain of CMV AD169 on the growth of isolated progenitors. Such differences between AD169 and lowpassage clinical isolates of CMV have been reported by others (6, (22) (23) (24) (21, 22, 28) . We therefore investigated what effect CMV had on stromal cell function by assaying conditioned medium from CMV-infected LTBMCs for its ability to stimulate colony formation by progenitor cells and by analyzing the expression of CSF genes in infected stromal cells. The former experiments demonstrated that conditioned medium from CMVinfected cultures specifically lacked activities capable of stimulating the growth of granulocytic colonies but did have burst-promoting activities. Assays for inhibiting activities were negative, suggesting that the lack of CFU-GM growth was due to the absence of colony-stimulating activities. By using a sensitive nuclease protection assay we could demonstrate that AD169-infected stromal cells lack G-CSF transcripts but have unaltered levels of GM-CSF, a result in keeping with the bioassay results and the data of Migliaccio et al., which showed that CFU-GM-stimulating activity is accounted for by G-CSF whereas the burst-promoting activity is attributable to GM-CSF (29) .
Analysis of CSF transcripts in stromal cells infected with clinical isolates of CMV presented a more complex picture.
Of two isolates tested, one showed evidence of a decrease in G-CSF transcripts, and one had no effect on growth factor mRNA levels. The latter isolate was one of the few found to infect granulocytic cells rather than stromal elements, further supporting the hypothesis that the myelosuppressive effects of this isolate may be by means of infection of myeloid cells. However, it is conceivable that this and the other CMV strains may have effects on the levels of other growth factors produced in LTBMCs. For example, others have shown that infection of monocytes with CMV abrogates their production of interleukin 1 (23) .
In conclusion, we have demonstrated that CMV-mediated myelosuppression can be produced in vitro, by means of infection of myeloid cells or infection of stromal cells.
Comparable mechanisms may be operant in vivo. Based on these data, it seems reasonable to suggest that in some patients with CMV-associated graft failure, treatment with specific growth factors may improve marrow function.
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